A New Audio Interview with Michael Llamas, President of Medical Marijuana, Inc., is now at SmallCapVoice.com
AUSTIN, Texas, May 22, 2012 /PRNewswire/ — SmallCapVoice.com, Inc. announced today that a new audio interview with Medical Marijuana, Inc. (PINKSHEETS: MJNA) is now available. The interview can be heard at http://smallcapvoice.com/blog/5-21-12-smallcapvoice-interview-with-medical-marijuana-inc-pink-sheets-mjna.
Recent company activity and highlights:
The company earned net income of approximately $1.21 million on gross revenues of $1.79 million for the quarter ended March 31, 2012. This represents a gross revenue increase of 400 plus percent quarter-over-quarter when compared to revenue of $430,000 for the quarter ended December 31, 2011 and an accumulative 12,000 plus percent increase in revenue since the same quarter last year. Operating expenses were approximately $580,000 for the quarter.
DENVER, May 17, 2012 /PRNewswire/ — Medical Marijuana, Inc. (MJNA), has commenced the first step in the process for its 15c2-11 filing status with BMA Securities located in 608 Silver Spur Road, Suite 100, Rolling Hills Estates, CA 90274. The filing of a 15c2-11 is designed to allow non-reporting public company’s securities to be quoted on the National Association of Securities Dealers’ (“NASD”) Over-the-Counter Bulletin Board (“OTCBB”) by filing required disclosures. Once approved, this filing status causes another level of transparency which will be attractive to additional market makers and brokerage firms, thereby providing increased visibility to a broader set of investors.
SEATTLE, May 16, 2012 (GLOBE NEWSWIRE) — Plandai Biotechnology, Inc. (OTCBB:PLPL), a producer of highly bioavailable botanical extracts, today announced a preliminary agreement with ZZ2, a private farming conglomerate in Southern Africa and the largest producer of fresh tomatoes in the continent of Africa. Based on a long-standing working relationship, Dunn Roman Holdings Africa (Pty) Limited, a subsidiary of Plandai, will, under a new contract, acquire tomato waste from ZZ2 which will be processed to recover highly bioavailable antioxidants using the company’s exclusive Hydrodynamic Extraction System.
Company Sees 400 Plus Percent Quarter-over-Quarter and an Accumulative 12,000 Plus Percent Year-over-Year Revenue Growth Fueled by Licensing Agreements and Acquisitions
SAN DIEGO, May 15, 2012 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), one of the medical marijuana (MMJ) industry’s premier cannabis and hemp industry innovators, today announced its first quarter earnings. The company earned net income of approximately $1.21 million on gross revenues of $1.79 million for the quarter ended March 31, 2012. This represents a gross revenue increase of 400 plus percent quarter-over-quarter when compared to revenue of $430,000 for the quarter ended December 31, 2011 and an accumulative 12,000 plus percent increase in revenue since the same quarter last year. Operating expenses were approximately $580,000 for the quarter.
ATLANTA, May 14, 2012 (GLOBE NEWSWIRE) — OTC Stock Review announces that it has initiated coverage of Medical Marijuana Inc. (OTC:MJNA), which is the first publicly held company vested in the medical marijuana and industrial hemp markets. MJNA is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries.